210 related articles for article (PubMed ID: 17011880)
1. Allergic contact dermatitis caused by topical eye drops.
Spaeth GL
Am J Ophthalmol; 2006 Oct; 142(4):706. PubMed ID: 17011880
[No Abstract] [Full Text] [Related]
2. Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops.
Pérez-Rodríguez E; González-Pérez R; Poza P; Feliciano L; López-Correcher B; Matheu V
Contact Dermatitis; 2008 Jun; 58(6):370-1. PubMed ID: 18503690
[No Abstract] [Full Text] [Related]
3. [New drugs in glaucoma therapy].
Gramer E
Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
[No Abstract] [Full Text] [Related]
4. Systemic side effects of topical latanoprost.
Rajan MS; Syam P; Liu C
Eye (Lond); 2003 Apr; 17(3):442-4. PubMed ID: 12724721
[No Abstract] [Full Text] [Related]
5. Allergic contact dermatitis caused by latanoprost ophthalmic solution.
Lai CH; Lai IC; Chi CC
Eur J Ophthalmol; 2006; 16(4):627-9. PubMed ID: 16952108
[TBL] [Abstract][Full Text] [Related]
6. Contact dermatitis from levobunolol eyedrops.
Erdmann S; Hertl M; Merk HF
Contact Dermatitis; 1999 Jul; 41(1):44-6. PubMed ID: 10416712
[No Abstract] [Full Text] [Related]
7. Dermatological side effects of brimonidine: a report of three cases.
Sodhi PK; Verma L; Ratan J
J Dermatol; 2003 Sep; 30(9):697-700. PubMed ID: 14578562
[TBL] [Abstract][Full Text] [Related]
8. Serious spinal sequelae following the use of eye drops.
Park JC; Jones DH
Eye (Lond); 2010 Jun; 24(6):1109. PubMed ID: 19876072
[No Abstract] [Full Text] [Related]
9. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
Nakakura S; Nomura Y; Ataka S; Shiraki K
J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
[TBL] [Abstract][Full Text] [Related]
10. [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].
Veyrac G; Chiffoleau A; Cellerin L; Larousse C; Bourin M
Therapie; 1999; 54(4):494-6. PubMed ID: 10667120
[No Abstract] [Full Text] [Related]
11. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
Osborne SA; Montgomery DM; Morris D; McKay IC
Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
[TBL] [Abstract][Full Text] [Related]
12. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
Cates CA; Jeffrey MN
Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
[No Abstract] [Full Text] [Related]
13. Contact dermatitis caused by allergy to dorzolamide.
Linares Mata T; Pardo Sánchez J; de la Cuadra Oyanguren J
Contact Dermatitis; 2005 Feb; 52(2):111-2. PubMed ID: 15725294
[No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis from carteolol and timolol in eyedrops.
Quiralte J; Florido F; de San Pedro BS
Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865
[No Abstract] [Full Text] [Related]
15. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
16. Allergic contact dermatitis due to diclofenac sodium in eye drops.
Miyazato H; Yamaguchi S; Taira K; Asato Y; Yamamoto Y; Hagiwara K; Uezato H
J Dermatol; 2011 Mar; 38(3):276-9. PubMed ID: 21342231
[TBL] [Abstract][Full Text] [Related]
17. [Glaucoma and ocular surface].
Stefan C; Cojocaru I; Pop A
Oftalmologia; 2011; 55(1):30-3. PubMed ID: 21774383
[TBL] [Abstract][Full Text] [Related]
18. Latanoprost and periocular skin color changes.
Wand M; Ritch R; Isbey EK; Zimmerman TJ
Arch Ophthalmol; 2001 Apr; 119(4):614-5. PubMed ID: 11296032
[No Abstract] [Full Text] [Related]
19. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands.
Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
Cornea; 2012 Nov; 31(11):1229-34. PubMed ID: 22406943
[TBL] [Abstract][Full Text] [Related]
20. Heart block following topical latanoprost treatment.
De Smit E; Theodorou M; Hildebrand GD; Bloom P
BMJ Case Rep; 2011 Oct; 2011():. PubMed ID: 22679164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
